Key Takeaways
- AXT unveiled a public offering priced at $64.25 per share, targeting up to $632.5 million in total proceeds with underwriter options included
- Shares tumbled approximately 12% during premarket hours Tuesday after the offering announcement
- First-quarter revenue guidance stands at $26M–$28M, representing growth from $19.4M year-over-year, though a net loss of $1.6M–$2.6M is anticipated
- Capital raised will support capacity expansion at Beijing Tongmei facility focused on indium phosphide substrate manufacturing
- The pullback dampens an extraordinary 5,867% rally the stock experienced over the trailing 12-month period
AXT Inc. (AXTI) has emerged as one of Wall Street’s most explosive performers in recent memory. Delivering a staggering 5,867% return over just one year is exceptionally rare. Yet Tuesday morning brought a reality check, with the compound semiconductor specialist retreating approximately 12% in premarket action following disclosure of an equity raise.
Premarket trading showed the stock changing hands near $69.43, marking a decline from its previous closing level, when AXT commanded a market valuation of $4.38 billion.
Northland Securities is underwriting the transaction, which was priced at $64.25 for each share. The company is issuing 8,560,311 common shares, while granting underwriters a 30-day over-allotment option for an additional 1,284,046 shares. Base proceeds total approximately $550 million, potentially reaching roughly $632.5 million should underwriters exercise their full allocation. The transaction was scheduled to close on April 22.
According to AXT, the capital will predominantly support operations at its Beijing Tongmei Xtal Technology unit, which manufactures indium phosphide substrates distributed globally. Remaining funds are earmarked for research and development initiatives, working capital requirements, and general corporate activities.
The company’s entire executive leadership team and board of directors committed to a 60-day lock-up period on their holdings effective from the prospectus supplement date.
The Strategic Importance of Indium Phosphide
Indium phosphide substrates serve as critical components in optical networking equipment deployed within data center environments. Market demand has accelerated dramatically as artificial intelligence infrastructure expansion fuels requirements for ultra-fast data transmission capabilities. This favorable industry dynamic propelled AXT’s remarkable stock appreciation throughout the past year.
The manufacturer also produces gallium arsenide and germanium wafers, supplying diverse industries including 5G telecommunications, LED lighting systems, laser technology, sensing applications, and satellite photovoltaic cells. Its production operations are concentrated in China, where it maintains three manufacturing plants and holds minority ownership positions in 10 raw-material providers.
Notwithstanding the impressive equity performance, AXT’s financial statements reveal an enterprise still navigating toward sustained profitability. Management projects first-quarter revenue between $26 million and $28 million, representing improvement versus $19.4 million reported in the comparable prior-year period. However, the company anticipates recording a net loss ranging from $1.6 million to $2.6 million for the quarter.
Examining Current Valuation Metrics
Based on Monday’s closing price, AXT was valued at approximately 535 times forward earnings. Such an elevated multiple places significant pressure on operational delivery. Any indication of decelerating growth momentum or persistent losses can trigger substantial share price volatility.
The most current Wall Street analyst coverage assigns a Buy rating with a $90 price objective.
The offering was disclosed after Monday’s market close, prompting the sharp premarket decline observed Tuesday morning.


